Mehalick David

Mehalick David is listed in filings as CEO and President at Coeptis Therapeutics Holdings, Inc.. This profile follows SEC Form 4 activity through Feb 13, 2026, including 3 public disclosures. Recent filings connect the profile to Coeptis Therapeutics Holdings, Inc. (COEPW). The current snapshot covers public activity from Mar 6, 2025 to Feb 13, 2026. Reported amounts are shown as $1.0M to $304.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.